ArticleFrontiers in physiology2026
Ensemble fuzzy multilayer neural perceptron with optimized feature selection for cardiac disease prediction using MRI and ECG data.
Article in Frontiers in physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
One of the major causes of death in the general population is cardiovascular disease. Life-threatening cardiac disease is influenced by several factors, including age, gender, blood sugar, cholesterol, heart rate, and more. There are so many factors that it can be challenging for specialists to assess each one. The current approach utilizes electrocardiogram (ECG) data and magnetic resonance imaging (MRI) image features but suffers from poor performance and high error rates. To address this problem, we employ an ensemble-based fuzzy multilayer neural perceptron (EFMLNP) model to predict cardiac disease. Initially, an image from the University of California, Irvine (UCI) Machine Learning Repository was selected to analyze the prognosis of cardiovascular disease. To effectively replicate the raw data values in the dataset, a median box filter (MBF) is used to pre-process the MRI dataset, reducing irrelevant values. The second stage, segmentation, uses adaptive mean gray segmentation (AMGS) to initialize two clusters for regions of interest and non-interest. The dataset is then tested using a feature-selection method based on recursive spectral spider optimization (RSSO) to identify the most pertinent characteristics for diagnosing heart disease (optimal reduced-feature splitting). Lastly, we examine a machine learning feature-extraction model and perform test analysis on the reduced features. The proposed EFMLNP method is evaluated using metrics including precision, recall, and receiver operating characteristic (ROC). The experimental outcome demonstrates that the accuracy is 98.3%, the precision is 97.15%, the recall is 98.43%, the F1-score is 96.34%, and the ROC is 0.96.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.